Literature DB >> 30107269

FKBP5 polymorphisms and hypothalamic-pituitary-adrenal axis negative feedback in major depression and obsessive-compulsive disorder.

Alex Ferrer1, Javier Costas2, Javier Labad3, Neus Salvat-Pujol1, Cinto Segalàs4, Mikel Urretavizcaya5, Eva Real4, Aida de Arriba-Arnau1, Pino Alonso5, José M Crespo5, Marta Barrachina6, Carles Soriano-Mas7, Ángel Carracedo8, José M Menchón5, Virginia Soria9.   

Abstract

Major depressive disorder (MDD) and obsessive-compulsive disorder (OCD) have both been linked to abnormalities in the hypothalamic-pituitary-adrenal (HPA) axis. Polymorphisms in the genes involved in HPA axis activity, such as FKBP5, and their interactions with childhood trauma have been associated with stress-related mental disorders. Our goal was to study the role of FKBP5 genetic variants in HPA axis negative feedback regulation as a possible risk factor for different mental disorders such as MDD and OCD, while controlling for childhood trauma, anxiety and depressive symptoms. The sample included 266 participants divided into three groups: 1) MDD (n = 89 [n = 73 melancholic; n = 3 atypical]), 2) OCD (n = 51; 39% with comorbid MDD [n = 13 melancholic; n = 7 atypical]) and 3) healthy controls (n = 126). Childhood trauma, trait anxiety and depressive symptoms were assessed. HPA negative feedback was analyzed using the dexamethasone suppression test ratio (DSTR) after administration of 0.25 mg of dexamethasone. Twelve SNPs in the FKBP5 gene were selected for genotyping. Multiple linear regressions, after adjusting for the covariates considered, showed a reduced DSTR in individuals with the rs9470079-A variant that was significant after correction for multiple testing. Childhood trauma did not moderate the association between the rs9470079 and DSTR. Our results support the evidence that FKBP5 genetic variation could lead to abnormal HPA axis negative feedback independent of diagnosis. Therefore, this association can be identified as a transdiagnostic feature, offering an interesting opportunity to identify patients with higher stress vulnerability. Further studies focusing on the influence of FKBP5 on measurable biological endophenotypes are needed.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cortisol; Dexamethasone suppression test; FKBP5; HPA axis; Major depression; OCD; Trait anxiety

Mesh:

Substances:

Year:  2018        PMID: 30107269     DOI: 10.1016/j.jpsychires.2018.08.003

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  4 in total

Review 1.  The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.

Authors:  Eleni Pitsillou; Sarah M Bresnehan; Evan A Kagarakis; Stevano J Wijoyo; Julia Liang; Andrew Hung; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

2.  BDNF genetic variants and methylation: effects on cognition in major depressive disorder.

Authors:  Alex Ferrer; Javier Labad; Neus Salvat-Pujol; Marta Barrachina; Javier Costas; Mikel Urretavizcaya; Aida de Arriba-Arnau; José M Crespo; Carles Soriano-Mas; Ángel Carracedo; José M Menchón; Virginia Soria
Journal:  Transl Psychiatry       Date:  2019-10-21       Impact factor: 6.222

3.  Association of FKBP5 polymorphisms with patient susceptibility to coronary artery disease comorbid with depression.

Authors:  Haidong Wang; Chao Wang; Xingfa Song; Hai Liu; Yun Zhang; Pei Jiang
Journal:  PeerJ       Date:  2020-06-03       Impact factor: 2.984

4.  Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress.

Authors:  Xiaofei Zhu; Teng Li; En Hu; Lihua Duan; Chunhu Zhang; Yang Wang; Tao Tang; Zhaoyu Yang; Rong Fan
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.